Doubling the speed of cell line development in a large pharmaceutical company

5 Jul 2022

In this application note, Advanced Instruments describes how Solentim’s VIPS™ technology has helped the Cell Line Development group at Janssen R&D halve the time to develop the final cell cultures for manufacturing new biologic drugs, while still satisfying the clonality requirements of the Medicines’ Regulators.

Solentim VIPS®

Nova Biomedical (with Advanced Instruments)

Verified In-Situ Plate Seeding (VIPS), is a high-efficiency single cell seeder for use in high-value cell workflows.  VIPS combines single-cell cloning with an image-based ‘double lock’ of clonality assurance with imaging in both the droplet immediately after deposition and whole-well imaging post media fill, for a confident regulatory submission.  

(3)

Links

Tags

Doubling the speed of cell line development in a large pharmaceutical company